Trial
NCT02973191
A Study to Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Celgene
Collaborators
Juno
Condition
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Intervention
JCAR015
Why stopped
Development of JCAR015 has been discontinued. No subjects were enrolled/treated under protocol JCAR015-ALL-001
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-10